CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 23 filers reported holding CNS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,000 | -94.2% | 56,800 | -88.8% | 0.00% | – |
Q1 2022 | $173,000 | +66.3% | 506,532 | +242.9% | 0.00% | – |
Q4 2021 | $104,000 | -87.7% | 147,700 | -65.8% | 0.00% | -100.0% |
Q2 2021 | $847,000 | -51.0% | 432,109 | -40.2% | 0.00% | -50.0% |
Q1 2021 | $1,727,000 | – | 722,760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 20,745 | $41,000 | 0.00% |
Integrated Advisors Network LLC | 10,700 | $21,000 | 0.00% |
Alpha Cubed Investments, LLC | 11,000 | $22,000 | 0.00% |
Renaissance Technologies | 432,109 | $847,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 11,061 | $22,000 | 0.00% |
Sterling Financial Planning, Inc. | 600 | $1,000 | 0.00% |
UBS Group AG | 4,676 | $9,000 | 0.00% |
Capital Analysts, LLC | 1,000 | $2,000 | 0.00% |
OSAIC HOLDINGS, INC. | 5,000 | $10,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2,000 | $4,000 | 0.00% |